Malignant News and Research

RSS

Study provides novel insights into the molecular mechanisms of melanoma progression

Cong Peng et al., at Department of Dermatology, Xiangya Hospital, Central South University, China, conducted a study titled "NETO2 promotes melanoma progression via activation of the Ca²⁺/CaMKII signaling pathway" that investigates the role of Neuropilin and tolloid-like 2 (NETO2) in melanoma, a deadly form of skin cancer.

2 Aug 2024

Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain

A new pathway that is used by cancer cells to infiltrate the brain has been discovered by a team of Canadian and American research groups led by the Singh Lab at McMaster University.

2 Aug 2024

Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity.

1 Aug 2024

Discovery of potent immune cells near glioblastomas opens new avenues for treatment

Glioblastomas are highly aggressive, usually incurable brain tumors. If all therapeutic options are exhausted, patients have an average life expectancy of less than two years.

31 Jul 2024

Asbestos exposure and carcinogenicity: A comprehensive review

Asbestos, a group of naturally occurring fibrous minerals, has been historically used for its durability and resistance to heat.

29 Jul 2024

CHEST releases new clinical guideline for managing central airway obstruction

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on central airway obstruction (CAO).

24 Jul 2024

Kaempferol's promise in fighting triple-negative breast cancer

Review highlights kaempferol's potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.

24 Jul 2024

AI model Virchow outperforms clinical methods in cancer detection

In a recent study published in Nature Medicine, researchers demonstrated the use of the foundational model Virchow for computational analysis of pathological reports, prediction of biomarkers, and identification of cells across multiple cancer types. Virchow's pan-cancer model showed impressive accuracy, often outperforming clinical-grade models.

23 Jul 2024

Unraveling the role of TAL1 and miR-146b-5p in T-cell acute lymphoblastic leukemia

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form of leukemia that arises from the malignant transformation of T-cell progenitors.

23 Jul 2024

Fox Chase Cancer Center researchers identify new targets for mesothelioma prevention

A new research perspective was published in Oncoscience (Volume 11) on May 23, 2024, entitled, "Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma."

19 Jul 2024

Distinct signaling pathway drives the transformation of epithelial cells into aggressive tumors

A distinct signaling pathway called TNF-α drives the transformation of epithelial cells into aggressive tumor cells.

18 Jul 2024

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates.

16 Jul 2024

Triad of immune cells key to successful cancer immunotherapy, study finds

There's a frustrating fact about today's immunotherapies for cancer. While sometimes they work beautifully - completely eliminating or greatly reducing cancer in particular patients - other times they don't work at all. It's a mystery.

15 Jul 2024

Immunotherapy response assessment in malignant pleural mesothelioma: FDG-PET/CT vs. CT

A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, entitled, "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable malignant pleural mesothelioma."

15 Jul 2024

Blood cancer drug could help improve the efficiency of radiotherapy in meningiomas

Drugs developed to fight blood and other cancers could also help improve the efficiency of radiotherapy in the most commonly diagnosed low-grade brain tumour in adults, a new study has found.

10 Jul 2024

Novel device uses a simple blood test to detect early stage lung cancer

University of Queensland researchers have designed a device that uses a simple blood test to detect early stage lung cancer.

10 Jul 2024

Targeted alpha therapy offers hope for glioblastoma patients

A new approach to treating the most malignant type of brain cancer – glioblastoma – has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.

10 Jul 2024

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) in its collaboration with Fosun Pharma in June 2024, a potential innovative therapeutic using synthetic lethal strategy for the treatment of solid tumors.

5 Jul 2024

Innovative aptamer cream shows promise in treating allergic contact dermatitis in mice

Researchers at the University of Bonn have isolated a DNA molecule that is suitable for combating allergic contact dermatitis in mice.

4 Jul 2024

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality globally, exhibits a dismal five-year survival rate of only 18%.

2 Jul 2024

Malignant News and Research

Study provides novel insights into the molecular mechanisms of melanoma progression

Breakthrough research identifies pathway used by glioblastoma to infiltrate the brain

Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

Discovery of potent immune cells near glioblastomas opens new avenues for treatment

Asbestos exposure and carcinogenicity: A comprehensive review

CHEST releases new clinical guideline for managing central airway obstruction

Kaempferol's promise in fighting triple-negative breast cancer

AI model Virchow outperforms clinical methods in cancer detection

Unraveling the role of TAL1 and miR-146b-5p in T-cell acute lymphoblastic leukemia

Fox Chase Cancer Center researchers identify new targets for mesothelioma prevention

Distinct signaling pathway drives the transformation of epithelial cells into aggressive tumors

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Triad of immune cells key to successful cancer immunotherapy, study finds

Immunotherapy response assessment in malignant pleural mesothelioma: FDG-PET/CT vs. CT

Blood cancer drug could help improve the efficiency of radiotherapy in meningiomas

Novel device uses a simple blood test to detect early stage lung cancer

Targeted alpha therapy offers hope for glioblastoma patients

Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment

Innovative aptamer cream shows promise in treating allergic contact dermatitis in mice

Fibrinogen-like protein 1 plays dual role in liver regeneration and hepatocellular carcinoma recurrence

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News